Evidence map›Paper›PMID 35174149›Full record

ArticleFrontiers in bioengineering and biotechnology2021

Update of Argentina's Regulatory Policies on the Environmental Risk Assessment.

Facundo Vesprini, Agustina Ines Whelan, María Florencia Goberna, Mariana Lucía Murrone, Gabriela Evangelina Barros, Andrés Frankow, Perla Godoy, Dalia Marcela Lewi

Open access · goldAbstract read
In one paragraph

Article in Frontiers in bioengineering and biotechnology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Review
  3. Paraguay's approach to biotechnology governance: a comprehensive guide.Frontiers in bioengineering and biotechnology · 2024
    Article
  4. Review
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Facundo VespriniNational Directorate for Bioeconomy, Ministry of Agriculture, Livestock and Fisheries, Buenos Aires, Argentina.
Agustina Ines WhelanNational Directorate for Bioeconomy, Ministry of Agriculture, Livestock and Fisheries, Buenos Aires, Argentina.
María Florencia GobernaNational Directorate for Bioeconomy, Ministry of Agriculture, Livestock and Fisheries, Buenos Aires, Argentina.
Mariana Lucía MurroneNational Directorate for Bioeconomy, Ministry of Agriculture, Livestock and Fisheries, Buenos Aires, Argentina.
Gabriela Evangelina BarrosNational Directorate for Bioeconomy, Ministry of Agriculture, Livestock and Fisheries, Buenos Aires, Argentina.
Andrés FrankowNational Directorate for Bioeconomy, Ministry of Agriculture, Livestock and Fisheries, Buenos Aires, Argentina.
Perla GodoyNational Directorate for Bioeconomy, Ministry of Agriculture, Livestock and Fisheries, Buenos Aires, Argentina.
Dalia Marcela LewiNational Directorate for Bioeconomy, Ministry of Agriculture, Livestock and Fisheries, Buenos Aires, Argentina.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Environmental Risk Assessment (ERA) of genetically modified (GM) crops in Argentina is carried out by the National Advisory Commission on Agricultural Biotechnology (CONABIA) and the Innovation and Biotechnology Coordination (CIyB). Both have a large experience with this assessment, since 1991, when CONABIA was created. The continuous support to biotechnology as a state policy and as part of the decision to encourage developers in the regulatory process has helped make progress in the revision of the regulations. The experience gained during the last 30 years and the worldwide scientific advances supported the bases to update the regulatory framework. Focusing on the biosafety strengthening and the improvement of the applicant's experience in the GM crops evaluation process, during 2020 and 2021, the ERA went through a reviewing process. Some important modifications were made, such as (i) the assessment of stacked GM crops with focus on the possible interactions between transgenes and the expression products, (ii) the strengthening of the ERA taking into account the transportability of data and conclusions from the Confined Field Trials (CFTs), (iii) the adoption of Familiarity and History of Safe Use (HOSU) concepts on the risk assessment of the expression products, (iv) the special considerations for the unintended effects of insertional sites, and (v) as a post commercial release of GM crops, the Insect Resistance Management Plan (IRMP) was reformulated. These novel approaches enhance the ERA; they make it more efficient by applying the science criteria and the accumulated experience and scientific bibliography on the topic.

Indexed as

data transportabilityenvironmental risk assessmentfamiliarityGM crophistory of safe useinsects resistant management planstacked GM cropsunintended effects

Identifiers

PMID35174149
PMCPMC8841517
OpenAlexW4210770170

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.